序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
281 β-adrenergic receptor agonists JP2001543495 2000-12-06 JP4703081B2 2011-06-15 ジョン エイチ. グリッフィン,; ソッキ チェ,; エドマンド ジェイ. モーラン,
282 Synthetic methods and synthesizing apparatus of the array of Dna probe JP2000532704 1999-02-22 JP4698023B2 2011-06-08 ローランド グリーン; マイケル アール サッスマン; ガッソン サンギート シング; フランチェスコ セリーナ; フレデリック アール ブラットナー
The synthesis of arrays of DNA probe sequences, polypeptides and the like is carried out using a patterning process on an active surface of a substrate (12). An image is projected onto the active surface (15) utilizing an image former (11) that includes a light source that provides light to a micromirror device (35) comprising an array of electronically addressable micromirrors (36). The substrate (12) is activated in a defined pattern and bases are coupled at the activated sites, with further repeats until the elements of a two-dimensional array on the substrate have an appropriate base bound thereto. The micromirror array (35) can be controlled in conjunction with a DNA synthesizer to control the sequencing of images presented by the micromirror array (35) in coordination with the reagents provided to the substrate (12).
283 Bicyclic pyrazoles as kinase inhibitors, their process for preparing and pharmaceutical compositions containing them JP2002518217 2001-07-25 JP4555547B2 2010-10-06 バラジ,マリオ; ピツターラ,バレーリア; フアンチエツリ,ダニエーレ
284 High affinity nucleic acid ligand of complement system protein JP2010086118 2010-04-02 JP2010187687A 2010-09-02 BIESECKER GREGORY; GOLD LARRY
<P>PROBLEM TO BE SOLVED: To provide a method for identifying and preparing high-affinity nucleic acid ligands to complement system proteins. <P>SOLUTION: The method is for identifying and preparing high affinity nucleic acid ligands to complement system proteins C1q, C3 and C5, wherein specific RNA ligands for C1q, C3 and C5 identified by the SELEX method are included. <P>COPYRIGHT: (C)2010,JPO&INPIT
285 Oligomer and polymer of cyclic imino carboxylic acid JP2010019577 2010-01-29 JP2010168383A 2010-08-05 GELLMAN SAMUEL H; HUCK BAYARD R; RICHARDS MICHELE R
<P>PROBLEM TO BE SOLVED: To provide artificial polypeptide-like molecules, a method for producing combinatorial libraries using the residues, and the combinatorial libraries formed thereby. <P>SOLUTION: The artificial polypeptide-like molecules are oligomers and polymers of cyclic imino carboxylic acids comprising small groups represented by formulae (I). <P>COPYRIGHT: (C)2010,JPO&INPIT
286 Bicyclo-pyrazole as kinase inhibitor, method for producing the same and pharmaceutical composition comprising the same JP2009287171 2009-12-18 JP2010111677A 2010-05-20 FANCELLI DANIELE; PITTALA VALERIA; VARASI MARIO
<P>PROBLEM TO BE SOLVED: To provide a novel compound useful for treating diseases associated with dysregulated protein kinases. <P>SOLUTION: A bicyclo-pyrazole expressed by formula (I) and having kinase inhibition activity, a pharmaceutically accepted salt of the same and a pharmaceutical composition comprising the same are provided. <P>COPYRIGHT: (C)2010,JPO&INPIT
287 The combination oligomers and suitable libraries for their preparation, methods, kits, and compositions JP2002571915 2002-03-09 JP4408628B2 2010-02-03 ジェイムズ エム. クール,; テレサ クリーシー,; マーク ディー. クリストジャンソン,; ジェンス ジェイ. ヒルディッグ−ニールセン,; マーク ジェイ. フィアンダカ,
288 Detection of the interaction on the probe array JP2003523685 2002-09-02 JP4308652B2 2009-08-05 エーリヒト、ラルフ; エリンガー、トーマス; エルマントラウト、オイゲン; ヴェー. エンゲルス、ヨアヒム; ホルツァイ、ナンシー; ヤーン−ホフマン、ケルスティン
The invention concerns a method for detecting interactions between probe molecules and target molecules, whereby marking target molecules is not required. The invention further concerns probe arrays and kits suited to such a method, as well as a method for production, quality control and standardization of probe arrays.
289 Use as onium salt and its potential acid JP2002548218 2001-11-26 JP4294317B2 2009-07-08 真樹 大和; 斉 山戸; 敏景 朝倉; 啓 松本
290 Gene expression analysis using a plurality of potential JP2000187486 2000-06-22 JP4272800B2 2009-06-03 雅司 小川; 健一 山下; 快彦 牧野; 繁織 竹中; 義彦 阿部; 誠 高木
A method of detecting nucleic acid fragments in plural samples is performed by the steps of: attaching an electroconductive label to nucleic acid fragments in one sample and attaching a different electroconductive label to nucleic acid fragments in another sample; preparing a mixture of these samples; spotting the mixture on an electroconductive microarray having plural electrodes onto which probe molecules complementary to the nucleic acid fragments are fixed, so that hybridization between the nucleic acid fragments and the probe molecules on the electroconductive microarray can proceed to form hybrid structures; applying to the electrode an electric potential corresponding to the oxidation-reduction potential of the former label and detecting on the electrode an electric current; applying to the electrode an electric potential corresponding to the oxidation-reduction potential of the latter label and detecting on the electrode an electric current; and comparing the electric current detected in the former detecting procedure and that detected in the latter detecting procedure.
291 Functionalization process of the solid support, functionalized solid support, and use thereof JP2003513921 2002-07-05 JP4248393B2 2009-04-02 シェヴァリアー,イヴ; ステイランド,エリアン; ドゥガス,ヴィンセント
292 Molasses crystal composition and its manufacturing method JP2001560215 2001-02-14 JP4166980B2 2008-10-15 隆三 上野; 陽二郎 古川; 純哉 本多; 昭彦 田畑; 祥 荒井
293 Parallel Cellex JP51106296 1995-09-19 JP4153030B2 2008-09-17 イートン,ブルース; ゴールド,ラリー
294 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques JP2008054175 2008-03-04 JP2008200040A 2008-09-04 VAN NESS JEFFREY; TABONE JOHN C; HOWBERT J JEFFRY; MULLIGAN JOHN T
<P>PROBLEM TO BE SOLVED: To provide tags and linkers specifically designed for a wide variety of nucleic acid reactions. <P>SOLUTION: A method includes: (a) generating tagged nucleic acid molecules from one or more selected target nucleic acid molecules, wherein a tag is correlative with a particular nucleic acid fragment and detectable by non-fluorescent spectrometry or potentiometry, (b) separating the tagged molecules by size, (c) cleaving the tag from the tagged molecule, and (d) detecting the tag by non-fluorescent spectrometry or potentiometry, and therefrom determining the identity of the nucleic acid molecule. <P>COPYRIGHT: (C)2008,JPO&INPIT
295 Method and composition for determining sequence of nucleic acid molecule JP2008054176 2008-03-04 JP2008183012A 2008-08-14 VAN NESS JEFFREY; TABONE JOHN C; HOWBERT J JEFFRY; MULLIGAN JOHN T
<P>PROBLEM TO BE SOLVED: To provide a novel composition and a method that has largely increased speed and sensitivity in comparison with the conventional methods and can be used for determining the sequence of a nucleic acid molecule. <P>SOLUTION: This is a method for determining the sequence of nucleic acid molecules and comprises following steps: step (a) wherein the tagged nucleic acid fragments that are complementary to the selected target nucleic acid molecule, wherein the tag correlates to a specific nucleotide and can be detectable with non-fluorescence spectral analysis or potentiometry; step (b) wherein the tagged fragment is cut off from the tagged fragment according to length; step (c) wherein the tags are cut off from the tagged fragment, and step (d) wherein the tags are detected with the fluorescence spectral analysis or the potentiometry and the sequence of the nucleic acid molecule is determined therefrom. <P>COPYRIGHT: (C)2008,JPO&INPIT
296 Substituted triazine as a prion protein ligand, and, the use of the substituted triazine to detect or remove the prion JP2007523149 2005-07-25 JP2008508245A 2008-03-21 グーゲル、パトリック、バスコンセロス; タットン、ヘレン、ローズマリー; ピアソン、ジェームス、クリストファー
プリオン蛋白質を親和性結合させるための式(I)の化合物の使用であり、式中、R 1及びR 2は同じであっても異なっていてもよく、各々置換されていてもよいアルキル基、置換されていてもよいシクロアルキル基、置換されていてもよいアリール基又は置換されていてもよいヘテロアリール基であり;R 3素又はアリール基の置換基であるか、又はR 3はスペーサー分子を介して任意に結合した固体支持体であり;Zは酸素原子、硫黄原子又はNR 4を表し;Yは酸素原子、硫黄原子又はNR 5を表し;ここで、R 4及びR 5は同じであっても異なっていてもよく、水素、1〜6個の炭素原子を有する、置換されていてもよいアルキル、置換されていてもよいフェニル又は置換されていてもよいβ−フェニルエチルを表し;X 1及びX 2の一方は窒素原子を表し、X 1及びX 2の他方は窒素原子又はCR 6を表し、ここで、R 6は水素又はアリール基の置換基を表す化合物はプリオン蛋白質の親和性結合に有用である。
297 Pdz- domain interaction inhibiting small molecule JP2007520394 2005-06-30 JP2008505183A 2008-02-21 ロドニー キプリン ガイ; デービッド エム. ジャブロンズ; リャン ヨウ; 直明 藤井
PDZドメインの相互作用、特にMAGI中のPDZドメインの発癌性(腫瘍抑制因子)タンパク質PTENとの相互作用、およびディシュベルド(Dvl)タンパク質のPDZドメインのフリッツルド(Fz)タンパク質のような、他のタンパク質との相互作用を阻害する上で有効であることがわかった新規化合物は、一般式(I)または(III)を有する。 本発明はまた、そのような化合物の使用するタンパク質のスクリーニングおよび試験のためのコンビナトリアルライブラリー、アレイおよび方法を含む。 本発明の化合物は、Wntシグナル伝達を阻害するディシュベルドタンパク質(Dvl)を過剰発現するある種の細胞株においてアポトーシスを生じる。
298 Electrokinetic assembly was light control of particle proximity surface JP53836897 1997-04-24 JP4034351B2 2008-01-16 セウル,マイケル
299 Nucleic acid ligands JP2007075062 2007-03-22 JP2007195559A 2007-08-09 GOLD LARRY; TUERK CRAIG
<P>PROBLEM TO BE SOLVED: To provide a novel method for obtaining a ligand capable of specifically binding to a target molecule. <P>SOLUTION: Disclosed is a method comprising a specific in vitro binding of a nucleic acid ligand to a target molecule except binding between nucleic acids, wherein when the target molecule is a protein, the target molecule is a protein not to bind to a nucleic acid as a part of the biological functions. The nucleic acid ligand is also identified by a method comprising the following steps of: (a) contacting a nucleic acid mixture with the target under an advantageous condition for binding; (b) separating non-binding nucleic acids from the nucleic acid binding to the target; (c) dissociating the nucleic acid-target pair; (d) amplifying the nucleic acid dissociated from the nucleic acid-target pair to yield a ligand-enriched mixture; and (e) repeating the steps of binding, separating, dissociating and amplifying as necessary, thereby obtaining a ligand capable of specifically binding to the target molecule. <P>COPYRIGHT: (C)2007,JPO&INPIT
300 Fixing method to the carrier of biomolecules JP2002242456 2002-08-22 JP3888947B2 2007-03-07 竜一 小田; 直紀 木村
Fixing a biomolecule to a synthetic or natural resin-made carrier, comprising spotting a solution of biomolecules onto the carrier and irradiation with ultra-violet rays, is new. An independent claim is also included for producing a biomolecule-immobilized carrier by application of the above method.
QQ群二维码
意见反馈